A study to determine the safety and efficacy of duloxetine in the treatment of children and adolescents with depression. - Trial 2017-001598-18
Access comprehensive clinical trial information for 2017-001598-18 through Pure Global AI's free database. This phase not specified trial is sponsored by Eli Lilly and Company Limited and is currently status unknown. The study focuses on Major Depressive Disorder.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2017-001598-18
Trial Details
EU Clinical Trials Register • 2017-001598-18
A study to determine the safety and efficacy of duloxetine in the treatment of children and adolescents with depression.
Study Focus
Sponsor & Location
Eli Lilly and Company Limited
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
- Children of site personnel directly affiliated with this study and/or their immediate families.
ICD-10 Classifications
Recurrent depressive disorder, current episode mild
Depressive episode, unspecified
Depressive episode
Mild depressive episode
Recurrent depressive disorder, current episode moderate
Data Source
EU Clinical Trials Register
2017-001598-18
Non-Device Trial